Visby Medical’s FDA-cleared at-home PCR could reshape flu and COVID-19 testing
Discover how Visby Medical’s FDA-cleared at-home PCR could reshape flu and COVID-19 testing, treatment access, and diagnostics competition.
Medical Devices & Diagnostics
Pharma & Biotech
Can Bioxytran’s ProLectin-M accelerate viral clearance in mild COVID-19?
Bioxytran reports early antiviral signal for ProLectin-M. Discover what this means for COVID-19 treatment strategy and regulatory risk.
Medical Devices & Diagnostics
Why FDA’s clearance of ACON’s Flowflex Plus test marks a turning point in home diagnostics
FDA clears Flowflex Plus 4-in-1 test for RSV, flu, and COVID in infants and adults. Find out what this means for diagnostics, families, and industry players.
Pharma & Biotech
Hyundai Bioscience begins U.S. Phase 2 trial of Xafty for COVID, flu, and RSV
Hyundai Bioscience enters U.S. Phase 2 trials for Xafty, a broad-spectrum antiviral targeting flu, RSV, and COVID. Find out what this means for future pandemics.
Medical Devices & Diagnostics
Co-Diagnostics secures Australian patent for Co-Dx PCR platform, marking global IP expansion milestone
Co-Diagnostics, Inc. has received its first international patent for its Co-Dx PCR platform, with the Australian Patent Office granting coverage for the point-of-care molecular diagnostics system, including its PCR Pro instrument and disposable test cups. This development marks a critical step in the U.S.-based company’s international intellectual property strategy as it advances toward global commercialization